Literature DB >> 8095495

T cell response to embryonal carcinoma F9 cells: induction and characterization of T cell receptor alpha beta+ double-negative cytotoxic T lymphocytes.

M Imada1, S Fujimoto.   

Abstract

We investigated the mechanism of T cell response to murine embryonal carcinoma F9 cells. Thy-1+, CD4-, CD8- (double-negative) cytotoxic effector cells were induced in spleen cells obtained from immune A.BY mice to F9 cells, and the cytotoxic activity was major histocompatibility complex (MHC)-unrestricted. Furthermore, CD4+ T cells were essential for the induction of double-negative cytotoxic T lymphocytes directed to F9 cells. Most of the double-negative cytotoxic T lymphocyte lines obtained by long-term culture of the effector cells had CD3 molecule and T-cell receptor beta chain on their cell surface, and the CD3 molecule was found to be involved in target cell recognition. The T cell receptor alpha beta+ double-negative cytotoxic T lymphocyte line (2A5) also lysed various tumor cells in a non-MHC-restricted manner, but did not lyse concanavalin A-stimulated blasts of 129 strain, from which F9 cells had originated. These results indicate that T cell receptor alpha beta+ double-negative cytotoxic T lymphocytes induced by F9 cells recognize a common antigen(s) expressed on F9 cells and other tumor cells but not minor histocompatibility antigens.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095495      PMCID: PMC5919035          DOI: 10.1111/j.1349-7006.1993.tb02785.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  24 in total

1.  Unusual stage-specific embryonic antigen (TEC-4) defined by a monoclonal antibody to embryonal carcinoma cells defective in the expression of embryoglycan.

Authors:  P Dráber; J Nosek; Z Pokorná
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

Review 2.  Cloned T lymphocytes and monoclonal antibodies as probes for cell surface molecules active in T cell-mediated cytolysis.

Authors:  M Sarmiento; D P Dialynas; D W Lancki; K A Wall; M I Lorber; M R Loken; F W Fitch
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

Review 3.  Methods for the establishment of continuously growing cytolytic T cell clones.

Authors:  W Haas; H Von Boehmer
Journal:  J Immunol Methods       Date:  1982-07-30       Impact factor: 2.303

4.  Natural killer cells mediate lysis of embryonal carcinoma cells lacking MHC.

Authors:  P Stern; M Gidlund; A Orn; H Wigzell
Journal:  Nature       Date:  1980-05-29       Impact factor: 49.962

5.  Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1.

Authors:  J Ohara; W E Paul
Journal:  Nature       Date:  1985 May 23-29       Impact factor: 49.962

6.  Alkaline phosphatase activity in mouse teratoma.

Authors:  E G Berstine; M L Hooper; S Grandchamp; B Ephrussi
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

7.  Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression.

Authors:  K Ozato; D H Sachs
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

8.  The role of T cell receptors in non-MHC-restricted cytotoxicity.

Authors:  R J Lauzon; K A Siminovitch; J C Roder
Journal:  Cell Immunol       Date:  1989-02       Impact factor: 4.868

9.  CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection.

Authors:  M Mieno; R Suto; Y Obata; H Udono; T Takahashi; H Shiku; E Nakayama
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

10.  Augmentation of anti-tumor immunity in low-responder mice by various biological response modifiers: analysis of effector mechanism.

Authors:  T Toko; S Fujimoto
Journal:  Jpn J Cancer Res       Date:  1989-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.